![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 09, 2013 9:55:28 AM
Amarantus CEO to Present at the 15th Annual Rodman & Renshaw Global Investor Conference
SUNNYVALE, Calif., Sept. 9, 2013 (GLOBE NEWSWIRE) -- Amarantus Bioscience Holdings, Inc. (OTCQB:AMBS) a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to neurodegeneration and apoptosis, today announced that it's President & CEO Gerald Commissiong will make a corporate presentation at the 15(th) Annual Rodman & Renshaw Global Investor Conference in New York City on September 10(th) , 2013, sponsored by H.C. Wainwright & Co., LLC.
PRESENTATION INFORMATION AT A GLANCE:
WHO: Gerald Commissiong, President and Chief Executive
Officer
WHEN: September 10(th) , 2013 at 4:55pm ET
WHERE: Millennium Broadway Hotel in New York City, 145 West
44th Street, New York, NY
WEBCAST: http://wsw.com/webcast/rrshq23/ambs/
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM